VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AMGNAmgen Inc.
$368.10$198.7B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMGNPrice Target
AMGN logo

Amgen Inc. (AMGN) Price Target Analysis

Updated Jul 2, 2026
Analyst Rating: Buy
Based on 38 analysts

4.2% Above Target

AMGN trades 4.2% above Wall Street's consensus target of $352.50.

Current Price$368.10
Average Target$352.50
Target
Current
Low$185.00
Median$357.50
High$427.00

Analyst Target Range

Forward P/E16.4x
(Fair)
PEG Ratio5.59
(Expensive)
Implied Growth+56.1%
(High Growth)
Analyst Spread68.7%
(Wide Disagreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$368.10
Consensus$352.50
High$427.00
Low$185.00

Consensus Scenario Assumptions

The base valuation assumes AMGN achieves its forward estimates and maintains a stable P/E multiple of 16.4x. This scenario reflects the blended consensus of 38 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 38 published analyst recommendations for AMGN

34% hold / mixed conviction
+25
BearishBullish
Weighted analyst sentiment score based on 38 ratings
ConsensusBuy
Coverage38 Analysts
Net Score+25
Bull / Bear58% / 8%
Strong Buy00%
Buy2258%
Hold1334%
Sell38%
Strong Sell00%
Strong Buy
00%
Buy
2258%
Hold
1334%
Sell
38%
Strong Sell
00%
Recommendation Mix58% Buy · 34% Hold · 8% Sell
Buy (22)Hold (13)Sell (3)

AMGN Price Target Analysis

Updated July 8, 2026

As of July 8, 2026, Amgen Inc. (AMGN) has a Wall Street consensus price target of $352.50, based on estimates from 38 covering analysts. With the stock currently trading at $368.10, this represents a potential downside of -4.2%. The company has a market capitalization of $198.66B.

Analyst price targets range from a low of $185.00 to a high of $427.00, representing a 69% spread in expectations. The median target of $357.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.

The current analyst consensus rating is Buy, with 22 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 3 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, AMGN trades at a trailing P/E of 25.9x and forward P/E of 16.4x. The forward PEG ratio of 5.59 reflects a premium valuation. Analysts expect EPS to grow +56.1% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $484.50, with bear and bull scenarios of $305.23 and $638.38 respectively. Model confidence stands at 54/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+7.7%
Industry Consensus
Avg Forward P/E
19.2x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
GILD logo
GILDGilead Sciences, Inc.
$169.3B$136.36$161.81
+18.7%
Buy—58
BIIB logo
BIIBBiogen Inc.
$30.4B$205.70$218.32
+6.1%
Buy14.2x48
REGN logo
REGNRegeneron Pharmaceuticals, Inc.
$70.3B$676.23$836.00
+23.6%
Buy14.6x48
VRTX logo
VRTXVertex Pharmaceuticals Incorporated
$132.8B$522.25$556.00
+6.5%
Buy27.1x56
BMY logo
BMYBristol-Myers Squibb Company
$118.4B$57.97$62.60
+8.0%
Hold9.2x41
LLY logo
LLYEli Lilly and Company
$1.2T$1235.56$1269.94
+2.8%
Buy33.7x45
ABBV logo
ABBVAbbVie Inc.
$449.9B$254.65$258.00
+1.3%
Buy17.9x41
MRK logo
MRKMerck & Co., Inc.
$318.3B$128.86$133.77
+3.8%
Buy25.1x37
PFE logo
PFEPfizer Inc.
$136.9B$24.07$26.75
+11.1%
Hold8.1x39
JNJ logo
JNJJohnson & Johnson
$643.3B$267.24$253.42
-5.2%
Buy23.1x40

AMGN — Frequently Asked Questions

Quick answers to the most common questions about buying AMGN stock.

What is the AMGN stock price target for 2026?

Wall Street's consensus price target for AMGN is $352.5, -4.2% from its current price of $368.1. The below-market target from 38 analysts suggests limited near-term appreciation.

Is AMGN a buy, sell, or hold?

AMGN has a consensus rating of "Buy" based on 38 Wall Street analysts. The rating breakdown is predominantly bullish, with 22 Buy/Strong Buy ratings. The consensus 12-month price target of $352.5 implies -4.2% downside from current levels.

Is AMGN stock overvalued or undervalued?

With a forward P/E of 16.4454x, AMGN trades at a relatively low valuation. The consensus target of $352.5 implies -4.2% move, suggesting the market may be pricing in risks.

How high can AMGN stock go?

The most bullish Wall Street analyst has a price target of $427 for AMGN, while the most conservative target is $185. The consensus of $352.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $638 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover AMGN stock?

AMGN is heavily covered by Wall Street, with 38 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 22 have Buy ratings, 13 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the AMGN stock forecast?

The 12-month AMGN stock forecast based on 38 Wall Street analysts shows a consensus price target of $352.5, with estimates ranging from $185 (bear case) to $427 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $485, with bear/bull scenarios of $305/$638.

What is AMGN's fair value based on fundamentals?

Our quantitative valuation model calculates AMGN's fair value at $485 (base case), with a bear case of $305 and bull case of $638. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.

What is AMGN's forward P/E ratio?

AMGN trades at a forward P/E ratio of 16.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 25.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy AMGN stock?

Analysts are cautious on AMGN, with 3 Sell ratings and a price target of $352.5 (-4.2% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do AMGN price targets vary so much?

AMGN analyst price targets range from $185 to $427, a 69% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $352.5 consensus represents the middle ground. Our model's $305-$638 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Should I Buy AMGN?

Wall Street verdict, signals, and target summaries.

See Verdict

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare